- Global Pharma News & Resources

Press Releases - 2019-05-06

Date Title Company
06-May-2019 Affera's Technology For Cardiac Arrhythmia Treatment To Be Highlighted In 17 Scientific Sessions At The 2019 Heart Rhythm Society Meeting Affera, Inc.
06-May-2019 Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences Jazz Pharmaceuticals plc
06-May-2019 Syndax Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Clinical and Business Update Syndax Pharmaceuticals, Inc.
06-May-2019 Prostate Oncology Specialists Launches PROSTATE PROS Podcast to Educate Men with Prostate Cancer Prostate Oncology Specialists, Inc.
06-May-2019 Veloxis Pharmaceuticals Announces Financial Results for the First Three Months of 2019 Veloxis Pharmaceuticals
06-May-2019 FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin-mediated amyloidosis U.S. Food and Drug Administration
06-May-2019 Publications of Secarna Pharmaceuticals' immuno-oncology data in peer-reviewed scientific journals support potential of LNAplusTM antisense oligonucleotide platform for discovering novel cancer therapies Secarna Pharmaceuticals GmbH & Co. KG
06-May-2019 Banco Sabadell gives ADL Bionatur Solutions an upside potential of 78% ADL Bionatur Solutions
06-May-2019 MEDICLIN startet well into the FY 2019 MediClin AG
06-May-2019 DelMar Presents Data Supporting VAL-083 as Potential Treatment for Pediatric Brain Tumors at SNO Pediatric Neuro-Oncology Conference DelMar Pharmaceuticals, Inc.
06-May-2019 Original-Research: MagForce AG (von GBC AG) MagForce AG
06-May-2019 Curetis (CURE-NL): Partnering drives turn-round goetzpartners securities Limited
06-May-2019 SIME Completes Study Validating Clinical AI Platform in Neonatal Respiratory Care SIME
06-May-2019 SIME Completes Study Validating Clinical AI Platform in Neonatal Respiratory Care SIME
06-May-2019 AEVIS VICTORIA SA - General Meeting of Shareholders of 27 May 2019 AEVIS VICTORIA SA
06-May-2019 Harbour BioMed and Chia Tai Tianqing Pharmaceutical Group Ltd. Announce Strategic Alliance to Discover, Develop and Commercialize Innovative Biologics Harbour BioMed